Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,384 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06023706RecruitingPhase 3
Capsaicin patch for tailbone pain
This trial tests a capsaicin 8% patch — a pain-relieving skin patch — to see if it can reduce tailbone pain that has lasted more than 3 months. You may be eligible if you have tried other treatments without success and have nerve-related pain symptoms.
BrestAges 18 years+ - NCT06024421RecruitingPhase 1
Testing high doses of favipiravir in healthy volunteers
This study tests the safety and how the body processes very high doses of the antiviral drug favipiravir in healthy people. It helps find the highest dose that is still safe before testing in patients.
ParisAges 18–75 - NCT06025786Recruiting
Benazir Nashonuma Program impact on child growth
This study checks if a program called Benazir Nashonuma helps prevent stunting (being too short for their age) in children under five. It compares families enrolled in the program with those who are not, to see if it makes a difference.
Karachi, SindhAges 1 day–4.9 years - NCT06026189Recruiting
Reducing cystoscopy for blood in urine
This trial tests if we can safely skip a bladder camera test (cystoscopy) for people who have microscopic blood in their urine. If you meet certain criteria, you may not need the procedure.
RotterdamAges Any age - NCT06030349Recruiting
Breathing support for kids with Down syndrome and sleep apnea
This trial looks at how well non-invasive breathing machines help children with Down syndrome who have obstructive sleep apnea. It tracks their health and sleep over time to see if the treatment works and improves daily life.
DublinAges 6 months–16 years - NCT06031233RecruitingPhase 4
Shorter infusion times for cancer immunotherapy drugs
This trial tests if giving common immunotherapy drugs over a shorter time is safe. It may mean less time in the clinic for you.
ZwolleAges 18 years+ - NCT06032923RecruitingPhase 1/Phase 2
Does vitamin B3 boost help lupus symptoms?
This study tests whether a form of vitamin B3, called nicotinamide riboside, can improve immune function and reduce inflammation in women with mild to moderate lupus. It may help understand if boosting NAD+ levels offers a new way to manage the disease.
Bethesda, MarylandAges 18–120 - NCT06034002RecruitingPhase 1
Study of INCA033989 for myeloproliferative neoplasms
This trial tests a new drug, INCA033989, alone or with ruxolitinib for people with certain blood cancers called myeloproliferative neoplasms (MPNs). It may help those with a specific genetic change (CALR mutation) who have not had success with other treatments.
Duarte, CaliforniaAges 18 years+ - NCT06034678Recruiting
Food allergy mastery program for teens and their families
This trial tests a program to help teens with food allergies learn more about managing their condition and reduce its impact on daily life. It is for kids ages 10–14 who have had a common food allergy for at least one year.
Washington D.C., District of ColumbiaAges 10–14 - NCT06035120Recruiting
Sealing damaged lung parts in severe emphysema
This trial tests a new treatment called AeriSeal to seal off damaged parts of the lung in people with severe emphysema. It aims to help you breathe better by reducing the amount of air trapped in your lungs.
Phoenix, ArizonaAges 40–80 - NCT06036394Recruiting
AI for brain and spine radiation planning study
This study uses artificial intelligence to review radiation plans for patients with brain or spine tumors treated at Tata Memorial Centre between 2010 and 2022. It may help improve how radiation therapy is planned in the future.
Mumbai, MaharashtraAges 1 year+ - NCT06038019Recruiting
Food allergy threshold test and prediction study
This study looks at people with suspected or known food allergies to find out how much of a food it takes to cause a reaction. It uses an oral food challenge (eating the food under medical supervision) to predict your personal threshold.
Hamilton, OntarioAges 3 months–65 years - NCT06038162Recruiting
Kidney treatment for patients on ECMO
This study compares two ways of giving kidney dialysis to patients who are on a heart-lung bypass machine (ECMO). It aims to find which method works better for filtering the blood.
BordeauxAges 18 years+ - NCT06039111Recruiting
Comparing two dyes for lymph node mapping in vulvar cancer
This study compares two methods for finding the first lymph node (sentinel node) that may contain cancer in people with vulvar cancer. It uses a dye called indocyanine green alone or with a radioactive tracer (technetium) to see which approach works better for staging the disease.
Hamilton, OntarioAges 18 years+ - NCT06039644Recruiting
Probiotics for breast cancer patients on chemotherapy
This trial tests whether taking a probiotic supplement can help breast cancer patients going through chemotherapy. If you are between 20 and 80 years old, have stage I-III breast cancer, and are receiving certain chemo drugs, this study may be for you.
TaipeiAges 20–80 - NCT06041620Recruiting
Gene-edited stem cell therapy for beta-thalassemia
This trial tests a new treatment that uses your own blood stem cells, edited with CRISPR technology, to reduce or eliminate the need for blood transfusions in people with beta-thalassemia.
Tianjin, Tianjin MunicipalityAges 3–35 - NCT06041334Recruiting
Spina Bifida blood vessel study
This trial studies blood vessels in people with spina bifida using safe, non-invasive methods. It aims to better understand how the condition affects the body over time.
Rennes, CHU de RennesAges 6 years+ - NCT06043193Recruiting
Quality of life study for patients with neuroendocrine tumors getting internal radiation therapy
This study looks at how internal radiation therapy (RIV) affects quality of life in people with neuroendocrine tumors. It aims to understand how well patients tolerate this treatment and how it impacts daily life.
Saint-Priest-en-Jarez, Saint-EtienneAges 18 years+ - NCT06043596Recruiting
SafeSpace App Study for teens
This study tests a mobile app called SafeSpace that may help teens make healthy decisions about relationships and pregnancy. It is for 14- to 18-year-olds in the U.S. who were assigned female or intersex at birth.
Bethesda, MarylandAges 14–18 - NCT06043609Recruiting
Outcomes after fertility preservation for patients at risk
This study checks how well fertility preservation methods work for patients who might lose their ability to have children due to illness or treatments like strong medicines or surgery. If you're interested in saving your fertility, this trial helps figure out how successful those options can be.
Hong KongAges Up to 60 years - NCT06044077RecruitingPhase 3
Testing a new pneumonia vaccine in healthy people
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
Chengdu, SichuanAges 2 years+ - NCT06044441Recruiting
Proactive palliative support for advanced cancer
This study offers a proactive program of support and education for people with advanced cancer and their caregivers. It aims to improve quality of life by starting palliative care conversations early, even before symptoms get worse.
SingaporeAges 21–120 - NCT06045091RecruitingEarly Phase 1
BCMA-targeted CAR-NK cells for multiple myeloma or plasma cell leukemia
This trial tests an experimental therapy using immune cells (CAR-NK cells) designed to target and kill cancer cells in people with multiple myeloma or plasma cell leukemia that has returned or stopped responding to treatment. The goal is to see if it is safe and effective.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06046326Recruiting
Online support group for people with multiple chronic conditions
This trial tests whether a virtual community where people share experiences and advice can improve the health of adults with two or more long-term illnesses. You may be able to join if you are between 30 and 60 years old and have at least two chronic diseases.
Madrid, MadridAges 30–60
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,384 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.